TELA Bio Inc
TELA
Get informed when a big investor buys or sells
+ FollowMarket Cap$32.72M
Close$
$2.93
324.6% upside
Current Fair Value
324.6% upsideUndervalued by 324.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $32.72 Million |
|---|---|
| Enterprise Value | $49.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 1.34 |
| Outstanding Shares | 57,256,518 |
Return
| Return on Equity | 766.01% |
|---|---|
| Return on Assets | -57.00% |
| Return on Invested Capital | -64.22% |
Valuation & Multiples
| P/E Ratio | -0.93 |
|---|---|
| PEG | -10.33 |
| Price to Sales | 0.69 |
| Price to Book Ratio | -0.69 |
| Enterprise Value to Revenue | 0.61 |
| Enterprise Value to EBIT | -1.47 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.14 |
| Debt to Equity | -10.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$18.50 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$20.01 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 750,0000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 46.94%▼ 11.81% |
|---|---|
| Total Invested | $16.71M▼ 48.58% |
| Investors Holding | 36▼ 6.00% |
ESG Score
No data